Galectin Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $3.5M | 1.6M | 2.26 |
| 2024-03-31 | $1.7M | 713k | 2.39 |
| 2023-09-30 | $1.4M | 726k | 1.92 |
| 2023-06-30 | $1.1M | 770k | 1.44 |
| 2023-03-31 | $1.6M | 773k | 2.10 |
| 2022-12-31 | $871k | 771k | 1.13 |
| 2022-06-30 | $1.3M | 776k | 1.63 |
| 2021-06-30 | $2.6M | 794k | 3.25 |
| 2021-03-31 | $5.7M | 2.6M | 2.17 |
| 2020-12-31 | $5.7M | 2.6M | 2.20 |
| 2020-09-30 | $6.8M | 2.5M | 2.70 |
| 2020-03-31 | $5.0M | 2.6M | 1.96 |
| 2019-12-31 | $7.4M | 2.6M | 2.87 |
| 2019-09-30 | $8.5M | 2.3M | 3.68 |
| 2019-06-30 | $8.5M | 2.0M | 4.14 |
| 2019-03-31 | $3.0M | 596k | 5.06 |
| 2018-12-31 | $2.1M | 604k | 3.48 |
| 2018-09-30 | $3.6M | 602k | 6.05 |
| 2018-06-30 | $3.8M | 588k | 6.43 |
| 2018-03-31 | $930k | 196k | 4.74 |
| 2017-09-30 | $439k | 200k | 2.19 |
| 2014-06-30 | $7.0k | 491 | 14.26 |
| 2014-03-31 | $0 | 3 | 0.00 |